Donate
Australian & New Zealand Childrens Haematology/Oncology Group

ANZCHOG Children’s Cancer Clinical Trials Repository

Study Title
A phase I study of vinorelbine, cyclophosphamide and Rapamycin for recurrent malignancies in children
Protocol ID
ACCT007 (Rap-CV)
Disease (Sub Disease)
Malignancies
Diagnosis Stage
Relapsed/refractory
Location
NSW
Sponsor
Australian and New Zealand Children's Haematology Oncology Group
Trial Status
Open
Sites
The Children's Hospital at Westmead
Study Type
Treatment
Phase
Phase 1
Age Eligibility
up to 21 Years
ANZCTR
ACTRN12613000423718
Back to Registry
Study Title A phase I study of vinorelbine cyclophosphamide and Rapamycin for recurrent malignancies in children
Protocol ID ACCT007 (Rap-CV)
Disease (Sub Disease) Malignancies
Diagnosis Stage Relapsed/refractory
Location NSW
Sponsor Australian and New Zealand Children's Haematology Oncology Group
Links http://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?ACTRN=12613000423718
Trial Status Open
Trial Open Date 09/08/2019
Sites The Children's Hospital at Westmead /
Study Type Treatment
Phase Phase 1
Age Eligibility up to 21 Years
ANZCTR ACTRN12613000423718